Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol 2008; 14(13): 2100-2105 [PMID: 18395914 DOI: 10.3748/wjg.14.2100]
Corresponding Author of This Article
Professor Wei-Zheng Zeng, Department of Digestion, General Hospital of Chengdu Military Command, Chengdu 610083, Sichuan Province, China. wxllady@163.com
Article-Type of This Article
Rapid Communication
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Xiao-Ling Wu, Wei-Zheng Zeng, Ming-De Jiang, Jian-Ping Qin, Hui Xu, Department of Digestion, General Hospital of Chengdu Military Command, Chengdu 610083, Sichuan Province, China
ORCID number: $[AuthorORCIDs]
Correspondence to: Professor Wei-Zheng Zeng, Department of Digestion, General Hospital of Chengdu Military Command, Chengdu 610083, Sichuan Province, China. wxllady@163.com
Telephone: +86-28-86570347
Received: November 2, 2007 Revised: December 11, 2007 Published online: April 7, 2008
Abstract
AIM: To explore the anti-fibrotic effect of Oxymatrine on CCl4-induced liver fibrosis in rats and its modulation on the TGFbeta-Smad signaling pathway.
METHODS: One hundred healthy male SD rats were randomly divided into three groups: normal group (n = 20), treatment group of Oxymatrine (n = 40) and CCl4-induced fibrosis group (n = 40). Experimental hepatic fibrosis was induced by subcutaneous injection of carbon tetrachloride (CCl4 soluted in liquid paraffin with the concentration of 300 g/L, the dosage of injection was 3 mL/kg, twice per week for 8 wk). The treated rats received Oxymatrine via celiac injection at a dosage of 10 mg/kg twice a week at the same time. The deposition of collagen was observed with H&E and Masson staining. The concentration of serum TGF-β1 was assayed with ELISA. The gene expression of Smads and CBP (CREB binding protein) was detected with in situ hybridization (ISH) and immunohistochemistry (IH), respectively. All the experimental figures were scanned and analyzed with special figure-analysis software.
RESULTS: A significant reduction of collagen deposition and rearrangement of the parenchyma was noted in the liver tissue of Oxymatrine-treated rats. The semi-quantitative histological scores (2.43 ± 0.47 &mgr;m2vs 3.76 ± 0.68 &mgr;m2, P < 0.05) and average area of collagen in those rats were significantly decreased when compared with hepatic cirrhosis model rats (94.41 ± 37.26 &mgr;m2vs 290.86 ± 89.37 &mgr;m2, P < 0.05). The gene expression of Smad 3 mRNA was considerably decreased in the treated animals. The A value of Smad 3 mRNA was lower in the treated rats than the model rats (0.034 ± 0.090 vs 0.167 ± 0.092, P < 0.05). Contrarily, the A value of Smad 7 mRNA was increased considerably in the treated animals (0.175 ± 0.065 vs 0.074 ± 0.012, P < 0.05). There was an obvious decrease in the expression of CBP mRNA in treated rats as illuminated by a reduction of its A value when compared with model rats (0.065 ± 0.049 vs 0.235 ± 0.025, P < 0.001).
CONCLUSION: Oxymatrine is effective in reducing the production and deposition of collagen in the liver tissue of experimental rats. Oxymatrine could promote the expression of Smad 7 and inhibit the expression of Smad 3 and CBP in CCl4-induced hepatic fibrosis in SD rats, could modulate the fibrogenic signal transduction of TGFβ-Smad pathway.
Citation: Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol 2008; 14(13): 2100-2105
Several studies have shown that hepatic fibrosis is a reversible disease, therefore an effective treatment would probably prevent or reverse the fibrotic process in the liver[1]. In the long pathological period of hepatic fibrosis to cirrhosis, transforming growth factor beta 1 (TGFβ1) is one of the strongest pro-fibrotic cytokine[23], and TGFβ-Smad signaling is the cardinal signal transduction pathway[4] which has been verified by several related studies. The down regulation of TGFβ expression and modulation of TGFβ-Smad signaling may be effective in preventing liver fibrosis[5]. This study is aimed to explore the anti-fibrotic effect and the probable mechanisms of the extraction of the traditional Chinese medicine, Oxymatrine, in experimental hepatic fibrosis of rats. By examining histopathological changes and deposition of collagen protein in the liver tissue with H&E and Masson staining, detecting the expression of Smads and CBP with in situ hybridization (ISH) and immunohistochemistry (IH), assaying the concentration of serum TGFβ1 with ELISA, we present anti-fibrotic effects of Oxymatrine and discuss the molecular mechanism in an experimental model of carbon tetrachloride (CCl4)-induced hepatic fibrosis in rats.
MATERIALS AND METHODS
Animals
One hundred healthy male SD rats (weight 140-160 g) were obtained from the Experimental Animal Center of Sichuan University (Chengdu, Sichuan Province, China).
Reagents
Carbon tetrachloride (CCl4) was obtained from the Chemical and Industrial Reagent Institute in Chengdu. Oxymatrine was from Green Valley Pharmaceutical Co. Ltd., Shanghai, China. Commercial Rat TGFβ1 ELISA Kit and Smad 7 IH Kit were obtained from Boster Biotechnology Co. Ltd., Wuhan, China. The oligonucleotide probe of Smad 3 mRNA (5'→3'): Biotin-GAAGGCCGGCTCACAGTAGGTGACTGGCTG (981-1010 bp, GC% = 63.33), Smad 7 mRNA (5’→3’):Biotin-GAGCTGTCCGAGGCAAAAGCCATTCCCCTG (2310-2339 bp, GC% = 60.00), and CBP mRNA (5’→3’): Dig-TGACAGTTGTTTATGTTTGGACGC (371-394 bp, GC% = 41.67) were obtained from Shanghai Shenergy Biotechnology Co. Ltd.
Methods
The experimental rats were housed in a room with controlled temperature (15°C-20°C) and lighting (10 h light, 14 h dark). Free access of water and food was allowed during the experimental period. All 100 rats were randomly divided into three groups: Control (n = 20), Treatment (n = 40) and Model group (n = 40). For the model group, 300 g/L CCl4 soluted in liquid paraffin was injected subcutaneously at a dosage of 3 mL/kg twice per week[6]. The treated rats received Oxymatrine celiac injections at 10 mg/kg twice a week besides the injection of CCl4. The injection of CCl4 and Oxymatrine were without anesthesia. There were no bleeding and other complications after injection. The control group was given normal food and water and received the same dosage and duration of liquid paraffin only as the model group. At the end of the 8-wk experimental period, all the rats were anaesthetized by an intra-muscular injection of sodium pentobarbital (30 mg/kg) before being put to death. Blood was collected from the heart and serum was obtained through centrifugation. The liver was removed rapidly and conserved in 40% neutral formalin for further examination.
Serum concentration of TGFβ1 was detected with enzyme-linked immunoadsorbent assay (ELISA). Liver samples were embedded in paraffin and stained with hematoxylin-eosin (H&E) and Masson collagen staining[7]. A total of five sections for each liver tissue sample were observed under an optical microscope. The semi-quantitative fibrosis staging scores were acquired according to the HAI[8] (histological action index, Table 1): 0: no fibrosis; 1: slight fibrosis, fibrosis located in the central liver lobule; 2: moderate fibrosis, fibrous space formation, but the structure of liver lobule reserved; 3: severe fibrosis, fibrous space enlarged and lobular structure distortion; 4: early cirrhosis or certain cirrhosis, pseudolobule formation.
Table 1 Semi-quantitative scores of hepatic fibrosis staging.
Score
Pathological description
Stage
0
No fibrosis
No fibrosis
1
Slight fibrosis
Periportal fibrosis
2
Medium fibrosis
Enlarged periportal fibrosis
3
Severe fibrosis
Bridging fibrosis
4
Cirrhosis
Cirrhosis
Each embedded liver sample in paraffin was sliced and fixed onto a poly-L-Lysine covered glass. The gene expression of Smad 3, Smad 7 and CBP mRNA in liver tissues were evaluated with in situ hybridization (ISH). The Oligonucleotide probes of Smad 3 and Smad 7 mRNA were marked with biotin at their 5’ ends. The Oligonucleotide probe of CBP mRNA was marked with digoxin at its 5’ end. The procedure of in situ hybridization (ISH) consisted of de-waxing, digesting, pre-hybridizing, hybridizing, coloring, and fixing[9]. For the color reaction of Smad 3 and Smad 7 mRNA, the NBT/BCIP method was used, and CBP mRNA was detected using DAB. Positive colors of these two methods were purple and brown, respectively. The expression of Smad 7 protein was detected with immunohistochemistry (IH). The procedure of immunohistochemistry (IH) consisted of de-waxing, exposing antigen, repairing antigen, blocking irrespective antigen, combining antigen and antibody, and coloring, respectively. For the color reaction DAB was used, and the positive result were brown particles in the cytoplasm[10].
Statistical analysis
The quantified markers were counted with mean ± SD. Slices were scanned under the inverted microscope attached to a computer. The figures were collected and quantified with the software of statistics system. (type TE2000-H, Nikon Ltd, Japan). Random analysis of variance was adopted in the comparison among the different groups, and t-test was used in the comparison between different groups.
RESULTS
At the end of experimental period, there were only eighty five rats remained. Five rats in treated group and ten in model group died. Most of the fifteen rats died from injury of biting or being poisoned by Carbon tetrachloride.
Change of TGFβ1 serum concentration
In the control group, the serum concentration of TGFβ1 was only at 1.34 ± 0.25 &mgr;g/L. In the model group, the serum concentration of TGFβ1 was significantly elevated to 3.59 ± 1.23 &mgr;g/L (P = 0.004 vs control group). It correlated with the semi-quantitative scores of liver fibrosis (the correlation coefficient r was +0.59, P < 0.05). With the administration of Oxymatrine, the serum concentration of TGFβ1 was decreased significantly to 1.82 ± 0.61 &mgr;g/L (P = 0.023 vs model group), although it was still higher than the serum concentration of the control group (P = 0.069 vs control group) (Table 2).
Table 2 Serum TGFβ1 concentration and collagen area in liver tissues (mean ± SD).
In the control group, the livers showed normal lobular architecture with central veins and radiating hepatic cords, with 0 staging score. Subcutaneous injection of CCl4 caused severe hepatic pathological damages such as inflammation, significant hepatic cell necrosis and excessive collagen deposition. The semi-quantitative hepatic fibrosis staging score was raised to 3.76 ± 0.68 in the model group (P < 0.01 vs control group). The rats’ livers in the Oxymatrine treated group showed less hepatic cells necrosis, less collagen deposition and a significantly decreased staging score of 2.43 ± 0.47 (P < 0.05 vs model group) (Table 3, Figure 1A and B).
Figure 1 Subcutaneous injection of CCl4 caused severe hepatic injury such as significant hepatic cell necrosis and excessive collagen deposition.
With Masson staining, the collagen fiber was shown blue and hepatic cells were red. ( A: Masson, × 200). Oxymarine treated livers showed less hepatic cell necrosis and less collagen deposition ( B: Masson, × 200).
Table 3 Liver histopathological semi-quantitative scores (According to HAI).
Molecular changes of Smad 3, Smad7 and CBP gene expression
There were less positive signals of Smad 3 and CBP mRNA detected with ISH (in situ hybridization) in the normal group. The A (optical density) value of CBP was nearly 0 (Table 2). In the model group, the positive expression of Smad 3 and CBP mRNA increased significantly. The A value of CBP and Smad 3 were increased to 0.235 ± 0.025 and 0.167 ± 0.092 respectively (P < 0.01 vs normal group). The treatment with Oxymatrine significantly reduced the A value to 0.065 ± 0.049 and 0.034 ± 0.090 (P < 0.05 vs model group). At the same time, the positive rate of Smad 7 protein expression was increased from 1.9% to 4.3% (P < 0.05 vs model group) (Table 2). Those results demonstrated that Oxymatrine was effective in inhibiting the expression of TGFβ1, Smad 3 and CBP, promoting expression of Smad 7 in the liver (Figures 2 and 3, Table 4).
Figure 2 Expression of Smad 7 protein in liver tissue of model rats was increased when detected with immunohistochemistry ( A: IH, × 200) when compared to the control group.
However, the expression of Smad 7 protein in the livers of the Oxymatrine-treated group was even more significantly increased ( B: IH, × 200). The positive rate of Smad 7 protein expression was 1.9% and 4.3% in the model group and the treated group, respectively (data obtained from statistical software, P < 0.05).
Figure 3 In the control group, the expression of CBP mRNA was at a very low level, the A (optical densit) value of it was nearly 0.
After CCl4 injection, the expression of CBP mRNA in the liver of fibrotic rats was significantly enhanced ( A: ISH, × 200). However, in the livers of the Oxymatrine-treated rats, the expression of CBP was also increased compared to the control group ( B: ISH, × 200), but it was significantly reduced compared to the model group. The A value of CBP mRNA in model group and treated group were 0.235 ± 0.025 and 0.065 ± 0.049, respectively (P < 0.05).
Table 4 Expression of Smad 3, Smad 7 and CBP in liver tissues.
Hepatic fibrosis is thought to be a reversible disease, however, there has not been a satisfied method in the clinical practice to reverse the pathological process yet. Several drugs, including antisense TGFβ receptor, cytokines[11], antioxidant, chemical drugs, soluble type II receptor of TGFβ1, antibody of TGFβ1 have been used in research work to block experimental hepatic fibrosis, but their effects were not as prosperous as we had expected. Besides, some traditional Chinese drugs have been found effective in preventing fibrogenesis and other causes of chronic liver injury[1213], and this help to develop a more hopeful future in controlling liver fibrosis and cirrhosis. These drugs have the advantages of being cheap, safe and easy to acquire, but most of them are limited in some animal experiments, rough clinical observation and lack of systemic study at molecular level.
The activation of hepatic stellate cells (HSC) “induced by some critical cytokines” is considered to be of great importance during the long period of liver fibrosis[14]. This activated HSC then becomes the main source of most cytokines and collagen proteins. Among the cytokines mediating factors, transforming growth factor beta 1 (TGFβ1) has been demonstrated in most research to be an essential pro-fibrogenesis factor[15–19]. In addition to that, TGFβ-Smad signaling pathway is the main pathway of TGF-β1[20–23], which transfers the stimulating signal from outside into the affected cells. The Smad proteins consists of a large family of transcription factors, which are also found in vertebrates, insects and nematodes. To date, Smads are the only TGF-β receptor substrates with a demonstrated ability to propagate signals. Briefly, two different transmembrane protein serine/threonine kinases, named as TGF-β receptor type I and II respectively, are brought together by the ligand, which acts as a receptor assembly factor[24]. Before this occurs, receptor I is inactive because a wedge-shaped GS region is inserted into the kinase domain, dislocating the catalytic center. During the TGF-ββ signal transduction, receptor II is activated firstly. TGF-β and its receptor then form a activated complex. In the ligand-induced complex, activated receptor II phosphorylates the GS region of receptor type I, resulting in the activation of the receptor I kinase. The type I receptors specifically recognize the Smad subgroup known as receptor-activated Smads (R-Smads), which are Smad 2 and Smad 3[25]. Then R-Smads are activated and forms a complex consisting of R-Smads and Smad 4, which belongs to Co-Smad. The Smads-complex then accumulates in the nucleus. This procedure leads to the formation of the functional transcriptional complexes. Both the R-Smads and the Co-Smads in this complex may participate in DNA-binding and recruitment of transcriptional cofactors[2627]. CBP (Creb binding protein) is the main downstream molecule and the general transcriptional co-activator. After transfering into the nucleus, the transcriptional complex bind to the certain domain of the target gene and cause the gene expression such as collagen production. The excess collagen production would lead to collagen deposition in liver tissue and hepatic fibrosis or cirrhosis at last. In this pathway, there are two inhibitant Smads (I-Smads), named as Smad 6 and Smad 7, which could combine to the Smads-complex in cytoplasm. Smad 6 and Smad 7 could prevent the Smads-complex to transfer into the nucleus, thus prevent the stimulating signal being transferred from outside into cell nucleus. Since the TGFβ-Smad signaling pathway is very important in the formation of hepatic fibrosis, inhibiting the transduction of it may inhibit hepatic fibrosis. As it was shown in some research, inhibiting the TGFβ-Smad signaling pathway or modulating the gene expression of certain Smads could interfere with hepatic fibrosis effectively[28].
Oxymatrine, which is the main component of Sophora flavescentis Ait, has been used clinically in preventing chronic liver disease[2930]. Many studies have shown that it has the effect of protecting hepatocytes, inhibiting the inflammation in liver and reducing the deposition of collagen protein. The present study aimed at exploring the potential mechanisms of Oxymatrine in the prevention of CCl4 -induced hepatic fibrosis in rats.
In this study, chronic administration of CCl4 caused liver fibrosis and cirrhosis in experimental rats, which is indicated by the histopathological and molecular biological changes in liver tissues. The serum concentration of TGFβ1 in the model group was significantly increased (3.59 ± 1.23 &mgr;g/L vs 1.34 ± 0.25 &mgr;g/L in the control group, P < 0.01), along with the significant collagen deposition. The collagen area was 290.86 ± 89.37 &mgr;m2, significantly higher than that of the control group (56.12 ± 21.45 &mgr;m2, P < 0.05). Under the optical microscope, the liver fibrosis/cirrhosis was verified by the classical liver structure: damage of liver lobular, hepatic cell necrosis and excessive collagen deposition. Some of the samples have even shown pseudo-lobular formation, which was a pathological symbol of liver cirrhosis. However, with the administration of Oxymatrine, the serum concentration of TGFβ1 was significantly decreased to 1.82 ± 0.61 &mgr;g/L (P < 0.05 vs model group). The HE and Masson stained histopathological slices showed mild necrosis and less collagen deposition. The semi-quantitative fibrosis staging scores were also decreased obviously (P < 0.01 vs model group). Since the main machanism of CCl4-induced liver fibrosis was toxicosis, there was slight inflammation in the livers of both groups. In the normal control group, the expression of Smad 3, Smad 7 and CBP were very low and could hardly be detected. Along with the formation of liver fibrosis, CCl4 injection also caused an increase in Smad 7, Smad 3 and CBP gene expression, and the expression of Smad 3 and CBP was increased more significantly than Smad 7. We could show that the expression of Smads in liver fibrosis was unbalanced compared to normal liver. The expression of Smad 7 protein and Smad 7 mRNA was increased in the Oxymatrine group compared to the model group. The percentage of Smad 7 protein was 0.019 ± 0.002 in the model group, while in Oxymatrine it was 0.043 ± 0.009 (P < 0.05 vs model group). The A value of Smad 7 mRNA was 0.074 ± 0.012 in the model group and 0.175 ± 0.065 in Oxymatrine group. The gene expression of Smad 3 mRNA and CBP mRNA were significantly increased in the model group and the O.D. value of them were 0.167 ± 0.092 and 0.235 ± 0.025, respectively. After Oxymatrine treatment, both Smad 3 and CBP mRNA were inhibited significantly (0.034 ± 0.090 and 0.065 ± 0.049, both P < 0.05) when detected with semi-quantitative evaluation after in situ hybridization. However, even with Oxymatrine treatment, Smad 3, Smad 7 and CBP expression remained still significantly increased compared to control group. The detection with in situ hybridization and immunohistochemistry could clearly show the change of molecular expression in liver tissue slice. The pathohistological damage of experimental liver could be revealed in the same visual field when the samples were observed under an optical microscope. However, the detection with in situ hybridization and immunohistochemistry could not gain an accurate quantity of the molecular expression.
In conclusion, the traditional Chinese medicine Oxymatrine shows significant anti-fibrotic effects in CCl4-induced liver fibrosis in rats. It can inhibit the expression of Smad 3 and CBP, and promotes the expression of Smad7. Further studies are needed to explore the exact molecular mechanisms of Oxymatrine in anti-fibrosis.
Footnotes
Supported by The Applied Basic Research of the Scientific and Technological Department of Sichuan Province, No. 05JY0492
Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.J Cell Mol Med. 2006;10:76-99.
[PubMed] [DOI][Cited in This Article: ]
Prosser CC, Yen RD, Wu J. Molecular therapy for hepatic injury and fibrosis: where are we?World J Gastroenterol. 2006;12:509-515.
[PubMed] [DOI][Cited in This Article: ]
Louis H, Le Moine O, Goldman M, Deviare J. Modulation of liver injury by interleukin-10.Acta Gastroenterol Belg. 2003;66:7-14.
[PubMed] [DOI][Cited in This Article: ]
Wu XL, Zeng WZ, Wang PL, Lei CT, Jiang MD, Chen XB, Zhang Y, Xu H, Wang Z. Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms.World J Gastroenterol. 2003;9:1559-1562.
[PubMed] [DOI][Cited in This Article: ]
Zhang G, Zhang FC, Wang TC, Liang KH. The effects of Chinese national medicine of Huoxueruanjian compound on SMAD signal in hepatic stellate cell and its significance.Zhonghua Ganzangbing Zazhi. 2004;12:213-215.
[PubMed] [DOI][Cited in This Article: ]
Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury.Hepatology. 2002;35:49-61.
[PubMed] [DOI][Cited in This Article: ]
Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.J Dermatol Sci. 2004;35:83-92.
[PubMed] [DOI][Cited in This Article: ]
Zimowska M. Signaling pathways of transforming growth factor beta family members.Postepy Biochem. 2006;52:360-366.
[PubMed] [DOI][Cited in This Article: ]
Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads.Annu Rev Cell Dev Biol. 2005;21:659-693.
[PubMed] [DOI][Cited in This Article: ]
Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling.Nature. 2003;425:577-584.
[PubMed] [DOI][Cited in This Article: ]
Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.Mol Cell Biol. 2007;27:4488-4499.
[PubMed] [DOI][Cited in This Article: ]
Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction.Curr Opin Cell Biol. 2007;19:176-184.
[PubMed] [DOI][Cited in This Article: ]
Wicks SJ, Grocott T, Haros K, Maillard M, ten Dijke P, Chantry A. Reversible ubiquitination regulates the Smad/TGF-beta signalling pathway.Biochem Soc Trans. 2006;34:761-763.
[PubMed] [DOI][Cited in This Article: ]
Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.J Invest Dermatol. 2002;118:211-215.
[PubMed] [DOI][Cited in This Article: ]
Verrecchia F, Mauviel A. Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis.Curr Rheumatol Rep. 2002;4:143-149.
[PubMed] [DOI][Cited in This Article: ]
Lu LG, Zeng MD, Mao YM, Wan MB, Li CZ, Chen CW, Fu QC, Wang JY, She WM, Cai X. Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial.Zhonghua Ganzangbing Zazhi. 2004;12:597-600.
[PubMed] [DOI][Cited in This Article: ]
Liu J, Shi BN, He JF. Effect of oxymatrine on serum matrix metalloproteinase-2 and its inhibitor in patients with chronic hepatitis B and liver cirrhosis.Zhongguo Zhongxiyi Jiehe Zazhi. 2005;25:989-992.
[PubMed] [DOI][Cited in This Article: ]
